Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

HKPD

Cellyan Biotechnology Co., Ltd

CIK 0002007702 · Nasdaq

NasdaqHealth CareWholesale-Drugs, Proprietaries & Druggists' Sundries
$0.45
↑ 0.02 (5.35%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BearishOverall score · based on 2/4 lenses
FundamentalsOwnershipTechnicalsOptions

Risks: Fundamentals, Technicals; Excluded: Ownership, Options (no data)

Key stats

Market Cap
$4.98M
P/E Ratio
-184.17
EPS
-0.00
Dividend Yield
Not covered
52W Position
6%
Beta
0.83

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
0.97
P/S
0.25
EV/Revenue
0.32
ROE
-0.5%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 6%
$0.32$2.58

Latest Financials

2025-03-31 FY
Revenue
$20.31M
Net Income
-$27.06K
Total Assets
$9.42M
Free Cash Flow
$499.30K

Recent news